TR200103545T2 - Dolastatin 15-türevleri. - Google Patents

Dolastatin 15-türevleri.

Info

Publication number
TR200103545T2
TR200103545T2 TR2001/03545T TR200103545T TR200103545T2 TR 200103545 T2 TR200103545 T2 TR 200103545T2 TR 2001/03545 T TR2001/03545 T TR 2001/03545T TR 200103545 T TR200103545 T TR 200103545T TR 200103545 T2 TR200103545 T2 TR 200103545T2
Authority
TR
Turkey
Prior art keywords
group
monovalent
mammal
amino
formula
Prior art date
Application number
TR2001/03545T
Other languages
English (en)
Turkish (tr)
Inventor
Janssen Bernd
Barlozzari Teresa
Haupt Andreas
Zierke Thomas
Kling Andreas
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of TR200103545T2 publication Critical patent/TR200103545T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2001/03545T 1997-07-18 1998-07-07 Dolastatin 15-türevleri. TR200103545T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/896,394 US6143721A (en) 1997-07-18 1997-07-18 Dolastatin 15 derivatives

Publications (1)

Publication Number Publication Date
TR200103545T2 true TR200103545T2 (tr) 2002-06-21

Family

ID=25406130

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/03545T TR200103545T2 (tr) 1997-07-18 1998-07-07 Dolastatin 15-türevleri.
TR2000/00132T TR200000132T2 (tr) 1997-07-18 1998-07-07 Dolastatin 15 türevleri

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2000/00132T TR200000132T2 (tr) 1997-07-18 1998-07-07 Dolastatin 15 türevleri

Country Status (32)

Country Link
US (6) US6143721A (cg-RX-API-DMAC7.html)
EP (1) EP0991658B1 (cg-RX-API-DMAC7.html)
JP (4) JP4508413B2 (cg-RX-API-DMAC7.html)
KR (1) KR100579748B1 (cg-RX-API-DMAC7.html)
CN (1) CN1268636C (cg-RX-API-DMAC7.html)
AR (1) AR018501A1 (cg-RX-API-DMAC7.html)
AT (1) ATE314387T1 (cg-RX-API-DMAC7.html)
AU (1) AU750120B2 (cg-RX-API-DMAC7.html)
BG (1) BG65212B1 (cg-RX-API-DMAC7.html)
BR (1) BR9810911A (cg-RX-API-DMAC7.html)
CA (1) CA2296036C (cg-RX-API-DMAC7.html)
CO (1) CO4990967A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107047T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ303045B6 (cg-RX-API-DMAC7.html)
DE (1) DE69832982T2 (cg-RX-API-DMAC7.html)
DK (1) DK0991658T3 (cg-RX-API-DMAC7.html)
ES (1) ES2258819T3 (cg-RX-API-DMAC7.html)
HR (1) HRP980397A2 (cg-RX-API-DMAC7.html)
HU (1) HU228996B1 (cg-RX-API-DMAC7.html)
ID (1) ID24669A (cg-RX-API-DMAC7.html)
IL (1) IL133784A (cg-RX-API-DMAC7.html)
MY (1) MY135057A (cg-RX-API-DMAC7.html)
NO (1) NO326827B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ502296A (cg-RX-API-DMAC7.html)
PL (1) PL197884B1 (cg-RX-API-DMAC7.html)
PT (1) PT991658E (cg-RX-API-DMAC7.html)
RU (1) RU2195462C2 (cg-RX-API-DMAC7.html)
SK (1) SK286581B6 (cg-RX-API-DMAC7.html)
TR (2) TR200103545T2 (cg-RX-API-DMAC7.html)
TW (1) TW533217B (cg-RX-API-DMAC7.html)
WO (1) WO1999003879A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA986358B (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6686336B2 (en) 2000-02-08 2004-02-03 Federal Government As Represented By The Department Of Veterans Affaires N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents
US6884869B2 (en) * 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US7256257B2 (en) * 2001-04-30 2007-08-14 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
JP5042444B2 (ja) 2002-03-22 2012-10-03 エーザイ・アール・アンド・ディー・マネジメント株式会社 癌の処置におけるヘミアスタリン誘導体およびその利用法
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
EP2353611B1 (en) * 2002-07-31 2015-05-13 Seattle Genetics, Inc. Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
KR101520209B1 (ko) 2003-11-06 2015-05-13 시애틀 지네틱스, 인크. 리간드에 접합될 수 있는 모노메틸발린 화합물
WO2006063135A2 (en) * 2004-12-09 2006-06-15 Eisai R & D Management Co., Ltd. Tubulin isotype screnning in cancer therapy using hemiasterlin analogs
CA2607940C (en) 2005-05-18 2009-12-15 Aegera Therapeutics Inc. Bir domain binding compounds
SG171682A1 (en) 2006-05-16 2011-06-29 Aegera Therapeutics Inc Iap bir domain binding compounds
SG183044A1 (en) 2007-07-16 2012-08-30 Genentech Inc Humanized anti-cd79b antibodies and immunoconjugatesand methods of use
JP5469600B2 (ja) 2007-07-16 2014-04-16 ジェネンテック， インコーポレイテッド 抗ＣＤ７９ｂ抗体及びイムノコンジュゲートとその使用方法
DE102007039706A1 (de) 2007-08-22 2009-02-26 Erhard Prof. Dr.-Ing. Kohn Chemischer Sensor auf Diamantschichten
UA106586C2 (uk) 2008-01-31 2014-09-25 Дженентек, Інк. Анти-cd79b антитіла, і імунокон'югати та способи їх застосування
NZ600608A (en) 2009-12-18 2015-01-30 Idenix Pharmaceuticals Inc 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
TW201129384A (en) 2010-02-10 2011-09-01 Immunogen Inc CD20 antibodies and uses thereof
EP3263583A1 (en) 2010-02-12 2018-01-03 Pharmascience Inc. Iap bir domain binding compounds
AU2012395148B2 (en) 2012-11-24 2016-10-27 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
PT3122757T (pt) 2014-02-28 2023-11-03 Hangzhou Dac Biotech Co Ltd Ligantes carregados e as suas utilizações em conjugação
EP3689910A3 (en) 2014-09-23 2020-12-02 F. Hoffmann-La Roche AG Method of using anti-cd79b immunoconjugates
NZ737471A (en) 2015-06-15 2022-02-25 Hangzhou Dac Biotech Co Ltd Hydrophilic linkers for conjugation
WO2015151081A2 (en) 2015-07-12 2015-10-08 Suzhou M-Conj Biotech Co., Ltd Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
WO2018086139A1 (en) 2016-11-14 2018-05-17 Hangzhou Dac Biotech Co., Ltd Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers
AU2022338463A1 (en) 2021-09-03 2024-03-21 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention
JP2024541058A (ja) 2021-11-03 2024-11-06 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ． 抗体の特異的共役

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
ES2144421T3 (es) * 1991-08-09 2000-06-16 Teikoku Hormone Mfg Co Ltd Nuevo derivado tetrapeptidico.
US5533097A (en) * 1992-02-26 1996-07-02 Motorola, Inc. Portable communication system comprising a local and wide area communication units which can store a communication when the wide area communication system is not available
WO1993017388A1 (en) 1992-02-26 1993-09-02 Clark Paul C System for protecting computers via intelligent tokens or smart cards
JP3523253B2 (ja) * 1992-05-20 2004-04-26 アボット ゲーエムベーハー ウント カンパニー カーゲー ドラスタチン誘導体
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
DE69329425T2 (de) * 1992-12-16 2001-01-18 Basf Ag Dolastatin analog
US5554993A (en) 1994-01-04 1996-09-10 Panasonic Technologies, Inc. Global position determining system and method
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5554725A (en) * 1994-09-14 1996-09-10 Arizona Board Of Regents Acting On Behalf Of Arizona State University Synthesis of dolastatin 15
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5618232A (en) 1995-03-23 1997-04-08 Martin; John R. Dual mode gaming device methods and systems
US5970143A (en) 1995-11-22 1999-10-19 Walker Asset Management Lp Remote-auditing of computer generated outcomes, authenticated billing and access control, and software metering system using cryptographic and other protocols
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
AU728161B2 (en) 1997-01-10 2001-01-04 Silicon Gaming, Inc. Method and apparatus using geoographical position and a universal time to determination means to provide authenticated, secure, on-line communication between remote gaming locations
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6554705B1 (en) 1997-08-22 2003-04-29 Blake Cumbers Passive biometric customer identification and tracking system
US6629591B1 (en) 2001-01-12 2003-10-07 Igt Smart token
US6438382B1 (en) 2001-02-14 2002-08-20 Telefonaktiebolaget Lm Ericsson (Publ.) Expedited location determination in analog service areas

Also Published As

Publication number Publication date
NO20000231L (no) 2000-01-17
TW533217B (en) 2003-05-21
DE69832982D1 (de) 2006-02-02
IL133784A (en) 2005-09-25
CZ2000176A3 (en) 2001-06-13
MY135057A (en) 2008-01-31
AR018501A1 (es) 2001-11-28
EP0991658A1 (en) 2000-04-12
CO4990967A1 (es) 2000-12-26
HU228996B1 (hu) 2013-07-29
JP2001515010A (ja) 2001-09-18
DK0991658T3 (da) 2006-05-15
CN1268636C (zh) 2006-08-09
SK286581B6 (sk) 2009-01-07
NZ502296A (en) 2002-02-01
US7662786B2 (en) 2010-02-16
SK187999A3 (en) 2000-09-12
JP5122429B2 (ja) 2013-01-16
US20100099843A1 (en) 2010-04-22
PT991658E (pt) 2006-05-31
BR9810911A (pt) 2000-08-01
JP5047935B2 (ja) 2012-10-10
AU8475898A (en) 1999-02-10
TR200000132T2 (tr) 2000-05-22
CA2296036C (en) 2007-05-01
HRP980397A2 (en) 1999-04-30
KR20010021998A (ko) 2001-03-15
BG65212B1 (bg) 2007-07-31
NO20000231D0 (no) 2000-01-17
EP0991658B1 (en) 2005-12-28
US20030153505A1 (en) 2003-08-14
BG104089A (en) 2000-12-29
JP4508413B2 (ja) 2010-07-21
US20130046077A1 (en) 2013-02-21
US6143721A (en) 2000-11-07
IL133784A0 (en) 2001-04-30
RU2195462C2 (ru) 2002-12-27
ES2258819T3 (es) 2006-09-01
US6458765B1 (en) 2002-10-01
WO1999003879A1 (en) 1999-01-28
KR100579748B1 (ko) 2006-05-15
US8163698B2 (en) 2012-04-24
ATE314387T1 (de) 2006-01-15
AU750120B2 (en) 2002-07-11
HUP0004234A2 (hu) 2001-05-28
PL338144A1 (en) 2000-09-25
CN1264388A (zh) 2000-08-23
JP2012211164A (ja) 2012-11-01
CY1107047T1 (el) 2012-09-26
DE69832982T2 (de) 2006-08-24
JP2009137967A (ja) 2009-06-25
US7084110B2 (en) 2006-08-01
PL197884B1 (pl) 2008-05-30
HK1029125A1 (en) 2001-03-23
ZA986358B (en) 2000-01-17
CA2296036A1 (en) 1999-01-28
CZ303045B6 (cs) 2012-03-07
NO326827B1 (no) 2009-02-23
US20060270606A1 (en) 2006-11-30
ID24669A (id) 2000-07-27
HUP0004234A3 (en) 2001-08-28
JP2009137968A (ja) 2009-06-25

Similar Documents

Publication Publication Date Title
TR200103545T2 (tr) Dolastatin 15-türevleri.
TR200000481T2 (tr) N-Alkonoilfenilalenin türevleri.
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
PT1005445E (pt) Derivados de n-alcanoilfenilalanina
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
CY1113969T1 (el) Ανευ-αλβουμινης συνταγοποιησεις παραγοντα viii
PT2327719E (pt) Expressão híbrida e em série de proteínas de neisseria
WO2002048183A3 (en) Compositions of peptide crystals
DK1442058T3 (da) Peptider der er effektive til behandling af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
TR200200843T2 (tr) İşemi'nin Tedavisi için olan bileşikler
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
PT1149910E (pt) Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
DE60017141D1 (de) Replikationskompetente anti-tumor vektoren
NO955067L (no) FVII/TF peptider
BRPI0410655A (pt) composição farmacêutica, método de tratar ou prevenir uma infecção pelo vìrus da raiva em um indivìduo em necessidade deste tratamento, vetor de expressão de rhabdovìrus recombinante, célula hospedeira de mamìfero, método de produzir uma anticorpo recombinante humano neutralizante do vìrus da raiva em uma célula de mamìfero, e, uso de uma combinação
AU2001274421A1 (en) Compositions based on aminoacids, suitable for the treatment of heart failure
IL158433A (en) Toluene sulfonamide-containing anti-tumor composition and method of use thereof
WO2001043761A3 (en) Methods for treating and preventing damage to mucosal tissue
FR2781230B1 (fr) Derives de peptides utilisables comme inhibiteur selectif du site n-terminal de l'enzyme de conversion de l'angiotensine humaine
ATE263574T1 (de) Verwendung von canp-inhibitoren in pharmazeutischen zubereitungen
IT1276453B1 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro preparazione ed impiego.